Doctor profile · Federal record

Dr. Samar Charabaty, M.D.

Rheumatology Physician (CMS: Rheumatology) · Gilroy, CA

  • NPI 1467603365
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 24 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
7880 Wren Ave Ste C131
Gilroy, CA 950207801
(408) 848-2170
fax (408) 848-4244

Credentials & registration

NPPES · NUCC
NPI registered
October 2008 — 18 yrs on file
Profile last updated
March 6, 2026
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
California #A104924

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1467603365. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
48,287
Distinct HCPCS
10
Medicare allowed
$1,564,524
HCPCS Description Services Patients Avg allowed
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 21,300 29 $42
J1602 Injection, golimumab, 1 mg, for intravenous use 13,650 16 $13
J0897 Injection, denosumab, 1 mg 11,160 103 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 917 365 $152
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 484 83 $86
96372 Injection of drug or substance under skin or into muscle 397 134 $18
J3489 Injection, zoledronic acid, 1 mg 165 33 $9
96413 Administration of chemotherapy into vein, 1 hour or less 66 13 $156
96415 Administration of chemotherapy into vein, each additional hour 65 11 $37
99204 New patient office or other outpatient visit, 45-59 minutes 49 49 $198

In context: peer comparison

Among 1 peers in this city , average services per provider: 4,389. This provider delivers 11× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,771
Transactions
119
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 27 $591.81
Amgen Inc. 42 $432.10
UCB, Inc. 16 $208.58
PFIZER INC. 12 $129.55
AstraZeneca Pharmaceuticals LP 4 $72.80
Radius Health, Inc. 3 $54.66
Janssen Biotech, Inc. 2 $46.22
Fresenius Kabi USA, LLC 3 $45.79
Novartis Pharmaceuticals Corporation 3 $43.02
Alexion Pharmaceuticals, Inc. 2 $38.94
HOSPIRA, INC. 1 $23.40
Kiniksa Pharmaceuticals International, plc 1 $20.03
Mallinckrodt Hospital Products Inc. 1 $20.00
GlaxoSmithKline, LLC. 1 $15.80
Genentech USA, Inc. 1 $15.33

By nature of payment

Food and Beverage
$1,771

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,254
Patients
337
Total drug cost
$1,586,068
Drug Type Claims Patients Total cost
Methotrexate (Methotrexate Sodium) Brand 280 84 $13,328
Prednisone Generic 160 49 $1,988
Hydroxychloroquine Sulfate Generic 139 53 $7,624
Alendronate Sodium Generic 99 39 $2,267
Leflunomide Generic 80 23 $10,301
Rinvoq (Upadacitinib) Brand 72 0 $581,212
Tramadol Hcl Generic 70 0 $387
Gabapentin Generic 65 26 $1,827
Folic Acid Generic 54 21 $207
Prolia (Denosumab) Brand 50 29 $82,349

Frequently asked questions

Auto-generated from federal data
What is Dr. Samar Charabaty's medical specialty?
Dr. Samar Charabaty practices Rheumatology Physician in Gilroy, CA.
Where does Dr. Samar Charabaty practice?
Dr. Samar Charabaty practices at 7880 Wren Ave Ste C131, Gilroy, CA 950207801. Office phone: 4088482170.
What is Dr. Samar Charabaty's NPI?
Dr. Samar Charabaty's National Provider Identifier (NPI) is 1467603365, issued by NPPES.
Does Dr. Samar Charabaty accept Medicare assignment?
Yes. Dr. Samar Charabaty accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Samar Charabaty commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.